Pancreatic Cancer Research

ResearcherLyon 1 UniversitéActive in the last 2 years

Thomas Lambin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9437-0154; OpenAlex author ID A5007012132, A5053794603. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Advances in EUS-Guided Biliary Drainage for the Management of Pancreatic Cancer. Co-author DOI 10.3390/cancers17213428↗
  2. Pancreatic Ductal Adenocarcinoma: Current and Emerging Therapeutic Uses of Focused Ultrasound. First author DOI 10.3390/cancers14112577↗
  3. Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma. Co-author DOI 10.3748/wjg.v28.i13.1288↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bertrand Napoléon · 1 shared paper, 2025 · strength 0.42
  2. Mathieu Pioche · 2 shared papers, 2022 · strength 0.38
  3. Cyril Lafon · 2 shared papers, 2022 · strength 0.38
  4. Frédéric Prat · 1 shared paper, 2022 · strength 0.20
  5. Maxime Lafond · 1 shared paper, 2022 · strength 0.17
  6. David Melodelima · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.